Tyme Technologies Inc.
TYME:NASDAQ
Tyme Inc. is a clinical-stage biotechnology company developing novel cancer therapeutics, intended to be safe and effective across a broad range of tumor types. We are led by an experienced management team and advised by a distinguished board of directors. Tyme continues to build strong institutional collaborations that include Mt. Sinai, the Mayo Clinic and many others.
Streetwise Company Fact Sheet
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
